These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38692299)

  • 1. CAR T-Cell Therapy in Autoimmune Disease.
    Howard JF; Vu T; Mozaffar T
    N Engl J Med; 2024 May; 390(17):1629-1631. PubMed ID: 38692299
    [No Abstract]   [Full Text] [Related]  

  • 2. CAR T-Cell Therapy in Autoimmune Disease.
    De Benedetti F; Diomedi Camassei F; Locatelli F
    N Engl J Med; 2024 May; 390(17):1629. PubMed ID: 38692298
    [No Abstract]   [Full Text] [Related]  

  • 3. CAR T-Cell Therapy in Autoimmune Disease.
    Merkt W; Lorenz HM; Schmitt M
    N Engl J Med; 2024 May; 390(17):1628-1629. PubMed ID: 38692297
    [No Abstract]   [Full Text] [Related]  

  • 4. CAR T-Cell Therapy in Autoimmune Disease. Reply.
    Müller F; Mackensen A; Schett G
    N Engl J Med; 2024 May; 390(17):1631-1632. PubMed ID: 38692300
    [No Abstract]   [Full Text] [Related]  

  • 5. Chimeric antigen receptor T cell therapy: a new emerging landscape in autoimmune rheumatic diseases.
    Lyu X; Gupta L; Tholouli E; Chinoy H
    Rheumatology (Oxford); 2024 May; 63(5):1206-1216. PubMed ID: 37982747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully Human Anti-CD19 CAR T Cells Derived from Systemic Lupus Erythematosus Patients Exhibit Cytotoxicity with Reduced Inflammatory Cytokine Production.
    Dingfelder J; Aigner M; Taubmann J; Minopoulou I; Park S; Kaplan CD; Cheng JK; Van Blarcom T; Schett G; Mackensen A; Lutzny-Geier G
    Transplant Cell Ther; 2024 Jun; 30(6):582.e1-582.e10. PubMed ID: 38548226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dawn of CAR-T cell therapy in autoimmune diseases.
    Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
    Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAR T-cell therapy in autoimmune diseases.
    Schett G; Mackensen A; Mougiakakos D
    Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
    Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
    Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAR T cells for infection, autoimmunity and allotransplantation.
    Maldini CR; Ellis GI; Riley JL
    Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus.
    Radic M; Neeli I; Marion T
    Expert Opin Biol Ther; 2022 Apr; 22(4):499-507. PubMed ID: 35089116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highlight of 2023: CAR T cells driving precision therapy for autoimmune disease.
    Lee AY; Reed JH
    Immunol Cell Biol; 2024 Jul; 102(6):437-440. PubMed ID: 38693765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAR-T cell therapy in systemic lupus erythematosus and beyond: a brave new world?
    van Leuven SI; Duivenvoorden R
    Rheumatology (Oxford); 2024 May; 63(5):1192-1194. PubMed ID: 38377390
    [No Abstract]   [Full Text] [Related]  

  • 14. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
    Zhang PF; Xie D; Li Q
    Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE.
    Li M; Zhang Y; Jiang N; Ning C; Wang Q; Xu D; Wang Z; Lv L; Zhou D; Zeng X
    N Engl J Med; 2024 Jul; 391(4):376-378. PubMed ID: 39047248
    [No Abstract]   [Full Text] [Related]  

  • 16. CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.
    Mougiakakos D; Krönke G; Völkl S; Kretschmann S; Aigner M; Kharboutli S; Böltz S; Manger B; Mackensen A; Schett G
    N Engl J Med; 2021 Aug; 385(6):567-569. PubMed ID: 34347960
    [No Abstract]   [Full Text] [Related]  

  • 17. [CAR T-cell therapy in rheumatology-What we know so far?].
    Hagen M; Wirsching A; Bohr D; Taubmann J; Müller F; Mackensen A; Grieshaber-Bouyer R; Schett G
    Z Rheumatol; 2024 Aug; 83(6):485-491. PubMed ID: 38780637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease.
    Daamen AR; Lipsky PE
    Ann Rheum Dis; 2024 May; 83(6):696-699. PubMed ID: 38637134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma.
    Chow VA; Shadman M; Gopal AK
    Blood; 2018 Aug; 132(8):777-781. PubMed ID: 29914976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR T-cell perspectives in lupus.
    Gremese E; Bruno D; Ferraccioli G
    Lancet; 2024 Jul; 404(10450):336. PubMed ID: 39067896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.